Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Webcast

bluebird bio to Present at Jefferies Cell Therapy Virtual Summit


bluebird bio, Inc. (NASDAQ: BLUE) today announced that members of the management team will participate in the Jefferies Cell Therapy Virtual Summit, Tuesday, October 6, at 2:00 p.m. ET.

To access the live webcast of bluebird bio's presentation, please visit the "Events & Presentations" page within the Investors & Media section of the bluebird bio website at http://investor.bluebirdbio.com. Replays of the webcast will be available on the bluebird bio website for 90 days following the event.

About bluebird bio, Inc.

bluebird bio is pioneering gene therapy with purpose. From our Cambridge, Mass., headquarters, we're developing gene therapies for severe genetic diseases and cancer, with the goal that people facing potentially fatal conditions with limited treatment options can live their lives fully. Beyond our labs, we're working to positively disrupt the healthcare system to create access, transparency and education so that gene therapy can become available to all those who can benefit.

bluebird bio is a human company powered by human stories. We're putting our care and expertise to work across a spectrum of disorders, including cerebral adrenoleukodystrophy, sickle cell disease, ?-thalassemia and multiple myeloma, using three gene therapy technologies: gene addition; cell therapy and (megaTAL-enabled) gene editing.

bluebird bio has additional nests in Seattle, Wash., Durham, N.C., and Zug, Switzerland. For more information, visit bluebirdbio.com.

Follow bluebird bio on social media: @bluebirdbio, LinkedIn, Instagram and YouTube.

bluebird bio is a trademark of bluebird bio, Inc.


These press releases may also interest you

at 10:45
Biome Analytics, the leader in cardiovascular performance improvement solutions, is pleased to announce the launch of its latest innovation, the Biome Risk Audit. Developed to address challenges in risk reporting and documentation accuracy in...

at 10:45
The "New Frontier: Significant Advancements in Handheld Gaming PCs" report has been added to  ResearchAndMarkets.com's offering. This report delves into the product design of handheld gaming PCs and examines their potential future development. In...

at 10:45
Moleculin Biotech, Inc., (Moleculin or the Company), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses, today announced Walter Klemp, President and Chief Executive Officer of...

at 10:37
Reveal Technology, Inc. (Reveal), is proud to share that they have been granted a $3.2M research, development, testing and evaluation (RDT&E) contract award with the Marine Corps Warfighting Laboratory (MCWL)....

at 10:35
Zapata Computing, Inc. ("Zapata AI"), the Industrial Generative AI software company developing solutions to solve enterprises' most difficult, industrial-scale problems, announced today that it has completed its business combination with Andretti...

at 10:35
Ferretly, the most advanced AI-powered social media screen platform that enables organizations to surface candidate behaviors from public sourced information including social media, today announced a new integration with Greenhouse, the all-together...



News published on and distributed by: